NCT06329830

177Lu-PSMA, Niraparib/AA Plus Prednisone for Prostate Cancer

Public trial-level signal summary for this oncology Phase 2 record.

Record overview

Status and phase

Status: WITHDRAWN

Phase: PHASE1, PHASE2

Sponsor: Baptist Health South Florida

Condition: Metastatic Prostate Cancer, Castration-resistant Prostate Cancer, Metastatic Castration-resistant Prostate Cancer

Signal summary

Public flags

Status signal: Registry Stop Signal

Timeline signals: stale_update_signal

Results signal: Low Signal

Operational burden: rare_population_signal | strict_eligibility_signal

Stopped reason

Context when available

Funding for the study was withdrawn.